Prostate Cancer
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.
November 15, 2023
Association between prediagnostic PSA and prostate cancer probability in Black and non-Hispanic White men.
November 15, 2023
National long-term survival estimates after radical prostatectomy for prostate cancer.
November 14, 2023
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression.
November 14, 2023
Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation.
November 14, 2023
Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors.
November 14, 2023
The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.
November 13, 2023
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.
November 13, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
November 13, 2023
Radiation therapy margin reduction for patients with localized prostate cancer: A prospective study of the dosimetric impact and quality of life.
November 13, 2023
A contemporary review of the treatments and challenges associated with penile rehabilitation after radical prostatectomy including a proposed optimal approach.
November 10, 2023
Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: An interrupted time series analysis.
November 10, 2023
A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care.
November 10, 2023
Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer.
November 10, 2023